Ischemic preconditioning protects the pig liver by preserving the mitochondrial structure and downregulating caspase-3 activity

Journal of Investigative Surgery

Volumn 22, Issue 2, 2009, Pages 88-97

  Giovanardi, Rafael Omar ^a,b   Rhoden, Ernani Luis ^b   Cerski, Carlos Thadeu ^b   Salvador, Miriam ^a   Kalil, Antonio Nocchi ^c  

^a UNIVERSITY OF CAXIAS DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Caspase 3; Ischemia reperfusion; Ischemic preconditioning; Liver injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE FLOW; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GILT (SWINE); IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; LIVER BIOPSY; LIVER HISTOLOGY; LIVER ISCHEMIA; LIVER MITOCHONDRION; LIVER PROTECTION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; ULTRASTRUCTURE; ANIMAL; BILE; BLOOD; DRUG EFFECT; LIVER; METABOLISM; METHODOLOGY; MITOCHONDRION SWELLING; PHYSIOLOGY; SECRETION; SWINE; VASCULARIZATION;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILE; CASPASE 3; DOWN-REGULATION; FEMALE; ISCHEMIC PRECONDITIONING; LIVER; MITOCHONDRIA, LIVER; MITOCHONDRIAL SWELLING; SUS SCROFA; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 66149149814     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.1080/08941930802712995     Document Type: Article

References (44)

1. Selzner N, Rudiger H, Graf R, et al.. Protective strategies against ischemic injury of the liver. Gastroenterology. 2003;125:917-936.
2. Ben-Ari Z, Pappo O, Mor E. Intrahepatic cholestasis after liver transplantation. Liver Transpl. 2003;9:1005-1018.
3. Jaeschke H. Molecular mechanisms of hepatic ischemiareperfusion injury and preconditioning.AmJ Physiol Gastrointest Liver Physiol. 2003;284:G15-G26. (Pubitemid 36076246)
4. Glantzounis GK, Salacinski HJ, Yang W, et al.. The contemporary role of antioxidant therapy in attenuating liver ischemiareperfusion injury: a review. Liver Transpl. 2005;11:1031-1047.
5. Caldwell CC, Okaya T, Martignoni A, et al.. Divergent functions of CD4+ T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol. 2005;289:G969-G976.
6. Nieuwenhuijs VB, De Bruijn MT, Padbury RT, et al.. Hepatic ischemia-reperfusion injury: roles of Ca2+ and other intracellular mediators of impaired bile flow and hepatocyte damage. Dig Dis Sci. 2006;51:1087-1102.
7. Lee WY, Lee SM. Ischemic preconditioning protects postischemic oxidative damage to mitochondria in rat liver. Shock. 2005;24:370-375.
8. Murphy A. Potentialmechanisms of mitochondrial cytochromec release during apoptosis. Drug Dev Res. 1999;46:18-25.
9. ManciniM,Nicholson DW, Roy S, et al.. The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J Cell Biol. 1998;140:1485-1495.
10. Hubbard WJ, Bland KI, Chaudry IH. The role of the mitochondrion in trauma and shock. Shock. 2004;22:395-402.
11. LeeWY, Lee JS, Lee SM. Protective effects of combined ischemic preconditioning and ascorbic acid on mitochondrial injury in hepatic ischemia/reperfusion. J Surg Res. 2007;142:45-52.
12. Koti RS, Seifalian AM, Davidson BR. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig Surg. 2003;20:383-396.
13. Peralta C, Hotter G, Closa D, et al.. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology. 1999;29:126-132.
14. Koti RS, Seifalian AM, McBride AG, et al.. The relationship of hepatic tissue oxygenation with nitric oxide metabolism in ischemic preconditioning of the liver. Faseb J. 2002;16:1654-1656.
15. Peralta C, Bulbena O, Xaus C, et al.. Ischemic preconditioning: a defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation. 2002;73:1203-1211.
16. Sindram D, Rudiger HA, Upadhya AG, et al.. Ischemic preconditioning protects against cold ischemic injury through an oxidative stress dependent mechanism. J Hepatol. 2002;36:78-84.
17. Yadav SS, Sindram D, Perry DK, et al.. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology. 1999;30:1223-1231.
18. Wills ED. Mechanisms of lipid peroxide formation in animal tissues. Biochem J. 1966;99:667-676.
19. Reynolds ES. The use of lead citrate at high pH as an electronopaque stain in electron microscopy. J Cell Biol. 1963;17:208-212.
20. Altman DG. Statistics in medical journals: developments in the 1980s. Stat Med. 1991;10:1897-1913.
21. Spiegel HU, Bahde R. Experimental models of temporary normothermic liver ischemia. J Invest Surg. 2006;19:113-123.
22. Accatino L, Pizarro M, Solis N, et al.. Bile secretory function after warm hepatic ischemia-reperfusion injury in the rat. Liver Transpl. 2003;9:1199-1210.
23. Bowers BA, Branum GD, Rotolo FS, et al.. Bile flow-an index of ischemic injury. J Surg Res. 1987;42:565-569.
24. Nieuwenhuijs VB, De Bruijn MT, Schiesser M, et al.. Ischemic preconditioning and intermittent ischemia preserve bile flow in a rat model of ischemia/reperfusion injury. Dig Dis Sci. 2007:1159-1167. (Pubitemid 46626183)
25. Schulz R, Walz MK, Behrends M, et al.. Minimal protection of the liver by ischemic preconditioning in pigs. Am J Physiol Heart Circ Physiol. 2001;280:H198-H1207.
26. SzijartoA, HahnO, LotzG, et al.. Effect of ischemic preconditioning on rat liver microcirculation monitored with laser Doppler flowmetry. J Surg Res. 2006;131:150-157.
27. Hasegawa T, Malle E, Farhood A, et al.. Generation of hypochlorite-modified proteins by neutrophils during ischemia-reperfusion injury in rat liver: attenuation by ischemic preconditioning. Am J Physiol Gastrointest Liver Physiol. 2005;289:G760-G767.
28. Georgiev P, Navarini AA, Eloranta JJ, et al.. Cholestasis protects the liver from ischaemic injury and post-ischaemic inflammation in the mouse. Gut. 2007;56:121-128.
29. Caban A, Oczkowicz G, Abdel-Samad O, et al.. Influence of ischemic preconditioning and nitric oxide on microcirculation and the degree of rat liver injury in the model of ischemia and reperfusion. Transplant Proc. 2006;38:196-198.
30. Burra P, Chirizzi L, Cardin R, et al.. Warm hepatic ischemia in pigs: effects of L-arginine and oligotide treatment. J Invest Surg. 2001;14:303-312.
31. Cavalieri B, PerrelliMG,Aragno M, et al.. Ischemic preconditioning attenuates the oxidant-dependent mechanisms of reperfusion cell damage and death in rat liver. Liver Transpl. 2002;8:990-999.
32. Jaeschke H. Role of reactive oxygen species in hepatic ischemia-reperfusion injury and preconditioning. J Invest Surg. 2003;16:127-140. (Pubitemid 36926517)
33. Meguro M, Katsuramaki T,NagayamaM, et al..Anovel inhibitor of inducible nitric oxide synthase (ONO-1714) prevents critical warm ischemia-reperfusion injury in the pig liver. Transplantation. 2002;73:1439-1446.
34. Frey TG, Mannella CA. The internal structure of mitochondria. Trends Biochem Sci. 2000;25:319-324.
35. Wakabayashi T. Structural changes of mitochondria related to apoptosis: swelling and megamitochondria formation. Acta Biochim Pol. 1999;46:223-237. (Pubitemid 129632502)
36. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J. 1999;341(Pt 2):233-249.
37. Nieminen AL, Byrne AM, Herman B, et al.. Mitochondrial permeability transition in hepatocytes induced by t- BuOOH: NAD(P)H and reactive oxygen species. Am J Physiol. 1997;272:C1286-1294.
38. Yang J, Liu X, Bhalla K, et al.. Prevention of apoptosis by Bcl- 2: release of cytochrome-c from mitochondria blocked. Science. 1997;275:1129-1132.
39. Kluck RM, Bossy-Wetzel E, Green DR, et al.. The release of cytochrome-c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997;275:1132-1136.
40. Cursio R, Gugenheim J, Ricci JE, et al.. A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. Faseb J. 1999;13:253-261.
41. Miller DK. The role of the Caspase family of cysteine proteases in apoptosis. Semin Immunol. 1997;9:35-49.
42. Yang X, Chang HY, Baltimore D. Essential role of CED-4 oligomerization in CED-3 activation and apoptosis. Science. 1998;281:1355-1357.
43. Rudel T, Bokoch GM. Membrane and morphological changes in apoptotic cells regulated by Caspase-mediated activation of PAK2. Science. 1997;276:1571-1574.
44. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998;281:1312-1316.